title: Cutaneous granulomas during infliximab therapy for spondyloarthropathy.
authors.forename: Andra Economu
authors.initials: AE
authors.lastname: Dubosc
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Perroud
authors.forename: Martine
authors.initials: M
authors.lastname: Bagot
authors.forename: Valérie
authors.initials: V
authors.lastname: Farenq
authors.forename: Xavier
authors.initials: X
authors.lastname: Chevalier
authors.forename: Bernard
authors.initials: B
authors.lastname: Maitre
authors.forename: Pascal
authors.initials: P
authors.lastname: Claudepierre
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006099:Granuloma / Q000150:complications / Q000209:etiology*; D006801:Humans; D000069285:Infliximab; D017563:Lung Diseases, Interstitial / Q000150:complications / Q000209:etiology; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000209:etiology; D012871:Skin Diseases / Q000150:complications / Q000209:etiology*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab